International Isotopes Commercializes Radiolabled SARS-CoV-2 Antibody Test
The company announced earlier this year that it had been funding the research and development of an advanced COVID-19 test at a leading research hospital.
Read MorePosted by Andy Lundin | Dec 27, 2021 | Covid 19, Immunoassay Reagents & test Kits |
The company announced earlier this year that it had been funding the research and development of an advanced COVID-19 test at a leading research hospital.
Read MorePosted by Chris Wolski | Dec 24, 2021 | Cancer, Controls |
Twist Bioscience Corporation has launched the Twist cfDNA Pan-cancer Reference Standards for use liquid biopsy tests to detect cancer from blood samples.
Read MorePosted by Chris Wolski | Dec 24, 2021 | Covid 19 |
Aardvark Mobile Health is addressing testing shortages in New York City by sending dozens of its staff, testing trucks, and other equipment immediately.
Read MorePosted by Andy Lundin | Dec 23, 2021 | Company News, POC Reagents & Test Kits |
The company expects that the acquisition will streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion.
Read MorePosted by Andy Lundin | Dec 23, 2021 | Covid 19, Immunoassay Reagents & test Kits |
GENETWORx announced that it has testing capacity from previous investment in infrastructure to help meet COVID-19 testing demand.
Read More